HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical impact of segmentectomy compared with lobectomy under complete video-assisted thoracic surgery in the treatment of stage I non-small cell lung cancer.

AbstractBACKGROUND:
Segmentectomy for small or early stage non-small cell lung cancer (NSCLC) has been controversial. Further, video-assisted thoracic surgery (VATS) for lung cancer was accepted during the past decade. We here compared the outcome between VATS segmentectomy and VATS lobectomy for stage I NSCLC.
METHODS:
In the retrospective study, 109 consecutive patients in stage I underwent surgery at Oita University Hospital (Oita, Japan) between September 2003 and October 2008. VATS segmentectomy was performed in 38 patients and VATS lobectomy with systemic lymphadenectomy was performed in 71 patients. After clinicopathologic factors were compared in both groups, local recurrence rates and survivals were compared.
RESULTS:
Five of 38 VATS segmentectomy and eight of 71 VATS lobectomy patients relapsed during the follow-up period (median 27.5 mo). In the relapsed patients after VATS segmentectomy, three (7.9%) were local recurrences and two (5.3%) were distant metastases. On the other hand, four (5.6%) were local recurrence and four (5.6%) were distant metastases in the VATS lobectomy group. There was no significant difference between the two groups. Furthermore, there was no difference in recurrence-free and overall survival between segmentectomy and lobectomy.
CONCLUSIONS:
Although the sample size is small, VATS segmentectomy is one of the appropriate procedures for stage I NSCLC.
AuthorsShin-ichi Yamashita, Masao Chujo, Yozo Kawano, Michiyo Miyawaki, Keita Tokuishi, Kentaro Anami, Satoshi Yamamoto, Katsunobu Kawahara
JournalThe Journal of surgical research (J Surg Res) Vol. 166 Issue 1 Pg. 46-51 (Mar 2011) ISSN: 1095-8673 [Electronic] United States
PMID19560164 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Carcinoma, Non-Small-Cell Lung (mortality, secondary, surgery)
  • Disease-Free Survival
  • Female
  • Humans
  • Lung Neoplasms (mortality, pathology, surgery)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (mortality)
  • Pneumonectomy (methods, mortality)
  • Prognosis
  • Retrospective Studies
  • Survival Analysis
  • Thoracic Surgery, Video-Assisted (methods, mortality)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: